Cryopreservation of human failed-matured oocytes followed by in vitro maturation: vitrification is superior to the slow freezing method

Reproductive Biology and Endocrinology

Yunxia Cao²  Ping Zhou²  Qiong Xing²  Yu Liu²  ZhiGuo Zhang¹ 

[1] Anhui Provincial Key Laboratory of Population Health and Aristogenics, the People's Republic of China;Reproductive Medicine Centre, Department of Obstetrics and Gynecology, First Affiliated Hospital of Anhui Medical University, The People's Republic of China

关键词: development rates;    fertilization;    in vitro maturation rate;    survival rate;    vitrification;    slow-freezing;    cryopreservation of human failed-matured oocytes;   

Others  :  1151176
DOI  :  10.1186/1477-7827-9-156

 received in 2011-08-12, accepted in 2011-12-12,  发布年份 2011

【 摘 要 】

Background

Oocyte cryopreservation is an important method used in a number of human fertility circumstances. Here, we compared the survival, in vitro maturation, fertilization, and early embryonic development rates of frozen-thawed human immature oocytes using two different cryopreservation methods.

Methods

A total of 454 failed-matured oocytes [germinal vesicle (GV) and metaphase I (MI) stages] were collected from 135 patients (mean age 33.84 +/- 5.0 y) who underwent intracytoplasmic sperm injection (ICSI) cycles between February 2009 and December 2009 and randomly divided into a slow freezing group [1.5 mol/L-1, 2-propanediol (PROH) + 0.2 mol/l sucrose] and vitrification group [20% PROH + 20% ethylene glycol (EG) + 0.5 mol/l sucrose].

Results

The vitrification protocol yielded a better survival rate than the slow freezing protocol at each maturation stage assessed. Regardless of the maturation stage (GV + MI), the slow freezing protocol had a significantly lower survival rate than the vitrification protocol (p < 0.001). In addition, a significant difference was found in the survival rates between GV and MI oocytes regardless of the protocol used (90.1 vs. 64.7%, respectively; p < 0.01). We also found that the maturation rates of GV and MI oocytes from the slow freezing and vitrification groups were 16.7 vs. 24.4% and 50.8 vs. 55.4%, respectively. Regardless of the protocol used, the GV oocytes had significantly lower viability than MI oocytes after 36 h of in vitro maturation (21.2 vs. 54.0%, respectively; p < 0.01). In addition, the GV and MI oocytes from the slow freezing group had a markedly lower maturation rate than those from the vitrification group (33.6 vs. 43.1%, respectively), but no statistical difference was found between the two groups (P > 0.05). For the GV-matured oocytes, no fertilized eggs were obtained in the slow-freezing group, while a 19.0% (4/21) fertilization rate was observed in the vitrification group. For the MI-matured oocytes, fertilization rates for the slow freezing and vitrified groups were 36% and 61.1%, respectively, but no significant difference was found between the two groups (PIn the Methods section in the MS, all procedures were compliant with ethical guidelines, i.e. approved by the Ethical Committee of our university and Informed Consent signed by each patient. > 0.05). In the GV vitrification group, no embryo formed; however, in the MI slow freezing group, 12 oocytes were fertilized, but only two achieved cleavage and were subsequently blocked at the 2-cell stage. In the MI vitrification group, a total of 22 embryos were obtained, five of which developed to the blastocyst stage.

Conclusions

Vitrification is superior to the slow freezing method in terms of the survival and developmental rates for the cryopreservation of human failed-matured oocytes. In addition, GV oocytes appeared to be more resistant than MI oocytes to the low temperature and cryoprotectant used during cryopreservation.

【 授权许可】

   
2011 Zhang et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Gidoni Y, Holzer H, Tulandi T, Tan SL: Fertility preservation in patients with non-oncological conditions. Reprod Biomed Online 2008, 16(6):792-800.
• [2]Deepinder F, Agarwal A: Technical and ethical challenges of fertility preservation in young cancer patients. Reprod Biomed Online 2008, 16(6):784-791.
• [3]Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC: Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008, 89(3):567-572.
• [4]Borini A, Bianchi V: Cryopreservation of mature and immature oocytes. Clin Obstet Gynecol 53(4):763-774.
• [5]Paynter SJ: A rational approach to oocyte cryopreservation. Reprod Biomed Online 2005, 10(5):578-586.
• [6]Tucker MJ, Morton PC, Wright G, Sweitzer CL, Massey JB: Clinical application of human egg cryopreservation. Hum Reprod 1998, 13(11):3156-3159.
• [7]Wu J, Zhang L, Wang X: In vitro maturation, fertilization and embryo development after ultrarapid freezing of immature human oocytes. Reproduction 2001, 121(3):389-393.
• [8]Kuwayama M, Vajta G, Kato O, Leibo SP: Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005, 11(3):300-308.
• [9]Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A: Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 2006, 85(1):108-111.
• [10]Selman H, Angelini A, Barnocchi N, Brusco GF, Pacchiarotti A, Aragona C: Ongoing pregnancies after vitrification of human oocytes using a combined solution of ethylene glycol and dimethyl sulfoxide. Fertil Steril 2006, 86(4):997-1000.
• [11]Zhang ZG, Zhao JH, Wei ZL, Cong L, Zhou P, Cao YX: Human umbilical cord blood serum in culture medium on oocyte maturation In vitro. Arch Androl 2007, 53(6):303-307.
• [12]Chian RC, Buckett WM, Abdul Jalil AK, Son WY, Sylvestre C, Rao D, Tan SL: Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment. Fertil Steril 2004, 82(6):1675-1678.
• [13]Tucker MJ, Wright G, Morton PC, Massey JB: Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. Fertil Steril 1998, 70(3):578-579.
• [14]Shaw JM, Oranratnachai A, Trounson AO: Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology 2000, 53(1):59-72.
• [15]Chian RC, Gilbert L, Huang JY, Demirtas E, Holzer H, Benjamin A, Buckett WM, Tulandi T, Tan SL: Live birth after vitrification of in vitro matured human oocytes. Fertil Steril 2009, 91(2):372-376.
• [16]Cao Y, Xing Q, Zhang ZG, Wei ZL, Zhou P, Cong L: Cryopreservation of immature and in-vitro matured human oocytes by vitrification. Reprod Biomed Online 2009, 19(3):369-373.
• [17]Cao YX, Chian RC: Fertility preservation with immature and in vitro matured oocytes. Semin Reprod Med 2009, 27(6):456-464.
• [18]Cao YX, Xing Q, Li L, Cong L, Zhang ZG, Wei ZL, Zhou P: Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Fertil Steril 2009, 92(4):1306-1311.